Plus   Neg

Acura Pharmaceuticals (ACUR) Surged To An 8-Month High After Nexafed Launch

Acura Pharmaceuticals Inc. (ACUR) rose steadily during the first 45 minutes of trade Tuesday, before settling into a range. The stock closed up by 1.04 at $3.49 on the highest volume of the year.

Acura Pharmaceuticals added to yesterday's sharp gains and set over an 8-month high. The company announced the launch of Nexafed on Monday, a cold medicine with abuse-deterrent technology.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Follow RTT